Research ArticleClinical Sciences
Technetium-99m MAG3 Kit Formulation: Preliminary Results in Normal Volunteers and Patients with Renal Failure
Andrew Taylor, Dennis Eshima, Paul E. Christian, Wesley W. Wooten, Lori Hansen and Karen McElvany
Journal of Nuclear Medicine May 1988, 29 (5) 616-622;
Andrew Taylor Jr.
Dennis Eshima
Paul E. Christian
Wesley W. Wooten
Lori Hansen


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Technetium-99m MAG3 Kit Formulation: Preliminary Results in Normal Volunteers and Patients with Renal Failure
Andrew Taylor, Dennis Eshima, Paul E. Christian, Wesley W. Wooten, Lori Hansen, Karen McElvany
Journal of Nuclear Medicine May 1988, 29 (5) 616-622;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer
- Radionuclides in Nephrourology, Part 1: Radiopharmaceuticals, Quality Control, and Quantitative Indices
- 99mTc(CO)3(NTA) and 131I-OIH: Comparable Plasma Clearances in Patients with Chronic Kidney Disease
- Development of a Novel 99mTc-Chelate-Conjugated Bisphosphonate with High Affinity for Bone as a Bone Scintigraphic Agent
- 99mTc-MAEC Complexes: New Renal Radiopharmaceuticals Combining Characteristics of 99mTc-MAG3 and 99mTc-EC
- Effect of Protein Binding on Renal Extraction of 131I-OIH and 99mTc-Labeled Tubular Agents